ZBIO

ProShares UltraPro Short NASDAQ Biotechnology
ZBIO

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

ZBIO was delisted on the 27th of March, 2020.

Back to rankings

7 hedge funds and large institutions have $995K invested in ProShares UltraPro Short NASDAQ Biotechnology in 2018 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
7
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$411K
2
+$32K
3
+$24K
4
Morgan Stanley
Morgan Stanley
New York
+$12.6K
5
UBS Group
UBS Group
Switzerland
+$10.4K

Top Sellers

1
-$100K
2
-$11.8K
3
-$9K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$411K
2
$269K
3
$208K
4
$35K
5
$32K
6
$24K
7
$16K
8
–